Thomas Smith
Stock Analyst at Leerink Partners
(4.98)
# 62
Out of 4,690 analysts
685
Total ratings
56.4%
Success rate
51.2%
Average return
Main Sectors:
Stocks Rated by Thomas Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KROS Keros Therapeutics | Maintained: Buy | $35 → $23 | $11.08 | +107.58% | 53 | Aug 4, 2026 | |
| ALT Altimmune | Maintained: Buy | $10 | $3.11 | +221.54% | 2 | Jul 28, 2026 | |
| ARGX argenx SE | Maintained: Buy | $780 → $1,065 | $1,031.66 | +3.23% | 36 | Jul 24, 2026 | |
| CLDX Celldex Therapeutics | Maintained: Buy | $70 | $39.63 | +76.63% | 41 | Jul 22, 2026 | |
| AVTX Avalo Therapeutics | Initiated Coverage: Buy | $38 | $19.34 | +96.48% | 1 | Jul 6, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | n/a | $13.73 | - | 8 | Jun 12, 2026 | |
| XFOR X4 Pharmaceuticals | Initiated Coverage: Buy | $12 | $4.04 | +197.03% | 1 | Jun 2, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | n/a | $78.65 | - | 27 | Jun 2, 2026 | |
| EQ Equillium | Upgraded: Buy | $6 | $2.27 | +164.32% | 34 | May 28, 2026 | |
| RNAC Cartesian Therapeutics | Reiterated: Buy | n/a | $9.28 | - | 17 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $21.81 | +46.72% | 13 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $106 | $89.33 | +18.66% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $23.16 | +115.89% | 39 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $50 | $40.82 | +22.49% | 37 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $52 | $12.66 | +310.74% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $13.17 | +173.35% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.20 | - | 20 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $4.68 | +156.41% | 1 | Jan 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $32 | $8.48 | +277.58% | 18 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 102.00 | kr 43.20 | +136.11% | 1 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $32.78 | +259.98% | 38 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.71 | - | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $6.05 | +15.70% | 34 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $104 → $115 | $111.73 | +2.93% | 17 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 → $14 | $15.05 | -6.98% | 32 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $540.03 | n/a | 39 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $10.26 | n/a | 15 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.98 | n/a | 34 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $14.87 | n/a | 8 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $16.69 | n/a | 16 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $15.80 | n/a | 28 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $16.60 | n/a | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $4.01 | n/a | 25 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $1.10 | n/a | 9 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $33 | $118.81 | n/a | 5 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.06 | n/a | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2 | $28.18 | n/a | 16 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 5,169p | 126p | n/a | 1 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $21 | $9.11 | n/a | 1 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $6 | $2.18 | n/a | 1 | Sep 8, 2017 |
Keros Therapeutics
Aug 4, 2026
Maintained: Buy
Price Target: $35 → $23
Current: $11.08
Upside: +107.58%
Altimmune
Jul 28, 2026
Maintained: Buy
Price Target: $10
Current: $3.11
Upside: +221.54%
argenx SE
Jul 24, 2026
Maintained: Buy
Price Target: $780 → $1,065
Current: $1,031.66
Upside: +3.23%
Celldex Therapeutics
Jul 22, 2026
Maintained: Buy
Price Target: $70
Current: $39.63
Upside: +76.63%
Avalo Therapeutics
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $38
Current: $19.34
Upside: +96.48%
Climb Bio
Jun 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.73
Upside: -
X4 Pharmaceuticals
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.04
Upside: +197.03%
Disc Medicine
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $78.65
Upside: -
Equillium
May 28, 2026
Upgraded: Buy
Price Target: $6
Current: $2.27
Upside: +164.32%
Cartesian Therapeutics
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.28
Upside: -
May 15, 2026
Reiterated: Buy
Price Target: $32
Current: $21.81
Upside: +46.72%
Apr 13, 2026
Reiterated: Buy
Price Target: $106
Current: $89.33
Upside: +18.66%
Apr 6, 2026
Reiterated: Buy
Price Target: $50
Current: $23.16
Upside: +115.89%
Apr 2, 2026
Reiterated: Buy
Price Target: $52 → $50
Current: $40.82
Upside: +22.49%
Mar 6, 2026
Reiterated: Buy
Price Target: $42 → $52
Current: $12.66
Upside: +310.74%
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $36
Current: $13.17
Upside: +173.35%
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.20
Upside: -
Jan 11, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.68
Upside: +156.41%
Dec 15, 2025
Reiterated: Buy
Price Target: $25 → $32
Current: $8.48
Upside: +277.58%
Nov 26, 2025
Initiated Coverage: Buy
Price Target: kr 102.00
Current: kr 43.20
Upside: +136.11%
Oct 23, 2025
Reiterated: Buy
Price Target: $118
Current: $32.78
Upside: +259.98%
Oct 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.71
Upside: -
Oct 15, 2025
Reiterated: Buy
Price Target: $7
Current: $6.05
Upside: +15.70%
Oct 8, 2025
Reiterated: Buy
Price Target: $104 → $115
Current: $111.73
Upside: +2.93%
Oct 1, 2025
Maintained: Buy
Price Target: $73 → $14
Current: $15.05
Upside: -6.98%
Aug 19, 2025
Maintained: Buy
Price Target: n/a
Current: $540.03
Upside: n/a
Aug 18, 2025
Reiterated: Buy
Price Target: $26
Current: $10.26
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: $8
Current: $2.98
Upside: n/a
Apr 16, 2025
Maintained: Hold
Price Target: n/a
Current: $14.87
Upside: n/a
Aug 28, 2024
Reiterated: Buy
Price Target: $58
Current: $16.69
Upside: n/a
Aug 8, 2024
Maintained: Hold
Price Target: $5
Current: $15.80
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $6
Current: $16.60
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $7
Current: $4.01
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $46
Current: $1.10
Upside: n/a
Aug 7, 2024
Maintained: Hold
Price Target: $33
Current: $118.81
Upside: n/a
Mar 15, 2024
Maintained: Buy
Price Target: n/a
Current: $9.06
Upside: n/a
Aug 15, 2023
Downgraded: Hold
Price Target: $13 → $2
Current: $28.18
Upside: n/a
Aug 8, 2022
Maintained: Buy
Price Target: 5,169p
Current: 126p
Upside: n/a
Jan 17, 2019
Initiated Coverage: Hold
Price Target: $21
Current: $9.11
Upside: n/a
Sep 8, 2017
Initiated Coverage: Hold
Price Target: $6
Current: $2.18
Upside: n/a